[Prenatal diagnosis of carbamyl phosphate synthetase deficiency by fetal liver biopsy].
Carbamyl phosphate synthetase deficiency (CPSD) is one of the enzyme defects of the urea cycle and inherited as an autosomal recessive. A definitive enzymatic diagnosis of CPSD can be made by biochemical assay of liver biopsy material, but not of cultured fibroblasts. In pregnancy at risk for CPSD, prenatal diagnosis was attempted by fetal liver biopsy, performed at 22 weeks of gestation. CPS activity was present and a healthy baby was delivered at term. The technique employed for fetal liver biopsy is described together with an evaluation of its possible role in prenatal diagnosis.
Murotsuki
J
J
Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai.
Uehara
S
S
Okamura
K
K
Yajima
A
A
Kikuchi
M
M
Oura
T
T
Miyabayashi
S
S
D000592:Amino Acid Metabolism, Inborn Errors / Q000175:diagnosis*; D000641:Ammonia / Q000097:blood; D001706:Biopsy; D002222:Carbamoyl-Phosphate Synthase (Ammonia) / Q000172:deficiency*; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis*; D006801:Humans; D008099:Liver / Q000196:embryology / Q000201:enzymology* / Q000473:pathology; D009954:Ornithine Carbamoyltransferase / Q000378:metabolism; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods
D000641:Ammonia; D009954:Ornithine Carbamoyltransferase; D002222:Carbamoyl-Phosphate Synthase (Ammonia)